BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       


January Archive 2004 - have your press release here?

Integragen And Aventis In Collaboration Agreement for the Discovery of Genes Associated with Schizophrenia 

Unique Cell-based Bioassay Services SBH Sciences

BioPortfolio launches life science email news alert and press release service

CYCLACEL COMPLETES $39 MILLION PRIVATE PLACEMENT

SBH Sciences: Unique Cell-based Bioassay Services (Updated 04).

Biotech Tracker: Focus Limited to New Drugs at H&Q

BioPortfolio Bulletin - enhancing awareness and competitive advantage in the life sciences

Avidex and ChemOvation Extend Collaboration on Rheumatoid Arthritis Small Molecule

Affymetrix and Invitrogen Corporation Launch Reagents for GeneChip(R) Expression Array Platform

Strathmann Biotec And Qiagen Sign Manufacturing Agreement With Corautus Genetics For Vegf-2 Plasmid Production

Biotech Tracker: Actimmune Fails in HCV Trial

Syngene - GeneGenius Speeds up Quality Checking To Help Develop Effective and Inexpensive Anti-venom

Biotech Tracker: Targeted Genetics To Begin Rheumatoid Arthritis Gene Therapy Trials

Vernalis plc: interim results for the six months ended 31 October 2003

Northbank Strengthens PR team with New Account Manager

Driving innovation - Tecan demonstrates new products at LabAutomation2004 in San Jose, California, USA

Argenta Discovery Ltd Announces New Agreement with GlaxoSmithKline 

Aventis and Sanofi: Merger speculation continues

Biotech Tracker: Lorus Antisense Moves Forward

Biotech Tracker: Transkaryotic TKT Abandons U.S. Replagal Approval 

Urinary Incontinence: Growing market offers commercial opportunity

Affymetrix Announces Launch of Zebrafish and Xenopus laevis Arrays for Whole-Genome Expression Analysis

Curacyte announces successful completion of Phase II study for PHP in distributive shock

BioTech Stock Report: Celgene

Siegfried with strong fourth quarter

CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) and LONZA extend manufacturing agreement to supply clinical grade antibody drugs 

Syngene’s ChemiGenius2 at Harefield  Helps Advance Research in Treating Heart Failure

First Successful Certification Audit of a Biological Resource Center 

ASINEX Announces one year extension to Lead Optimization program with Avalon Pharmaceuticals

Oxford BioMedica's TroVax receives approval to start Phase II trials in colorectal cancer

US Patent Establishes Oxxon’s Leadership Position in Prime Boost Technology 

Biotech Tracker: Actimmune for IPF

Biotech Tracker: Xigris for Children

Biotech Tracker: Inhaled Insulins Continue To Be Unimpressive

SCYNEXIS Announces Appointment Of Three New Members 

Biotech Tracker: Prialt Back on the Road Towards FDA Approval

Biotech Tracker: Myriad and Abbott Expand Collaboration

Biotech Tracker: Celltech Presses Forward With CDP870 Trials

Biotech Tracker: ISIS 104838 Dosing Not Yet Optimal

Dow enters NIH research agreement to develop rapid vaccine production system

RZPD develops highly efficient products for genome research: siRNA resources for gene silencing

AllCells LLC celebrating its 5th birthday with promotion on G-CSF Mobilized PBMC, PB CD34+

Affymetrix and Caliper Life Sciences Collaborate on Instrument Automation for Target Preparation

Affymetrix Launches Plasmodium Anopheles genome GeneChipR Array for Malaria Study

NADAG and SiREEN announce merger to form SIRENADE Pharmaceuticals and launch 20 million Euro financing round

UK biotech company wins competition for space in Fairfax County BioAccelerator

Affymetrix Launches Consortia Design Program to Create Whole-Genome Arrays for Plant and Animal Research Communities

CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) ANNOUNCES CLINICAL TRIALS UPDATE

GENEREX REPORTS ON NOVEL MECHANISM FOR IMMUNOTHERAPY CURE OF PROSTRATE CANCER

 


BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.